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Letter to theEditor
Attributable Risk Calculations for
Testicular Microlithiasis
Iread with interest the study by Heller et al,
1
“Testicular Microlithiasis: Prevalence and
Association with Primary Testicular Neoplasm.”
The problem of testicular microlithiasis has
vexed radiologists and urologists for decades,
and the authors are to be commended on their
thoroughly documented and large cross-
sectional study. It remains unclear whether
microlithiasis is itself a risk factor for testicular
carcinoma or merely a marker for some other,
as yet unknown, risk factor or exposure. In a
cross-sectional study, a causal–temporal
sequence cannot be formally inferred. However,
if the sequence is presumed and microlithiasis
is directly treated as a risk factor for testicular
cancer, the data are subject to additional epide-
miologic analysis that may be of interest to
your readers.
As the authors enumerate in their Table 1,
the prevalence of testicular cancer was 11.6% in
men with microlithiasis, 1.5% in men without
microlithiasis, and 2.3% in the total study popu-
lation. The relative risk of testicular cancer is
thus 7.67 times higher in men with microlithia-
sis than it is in other men. How much of this
additional risk is actually attributable to the
presence of microlithiasis? The answer to this
question takes into account the overall preva-
lence of the risk factor in the population
and provides insight into the true effect of
the risk factor on the disease in the popula-
tion—the consideration that should drive policy
recommendations.
Among men with microlithiasis, the excessive
occurrence of testicular cancer is simply the dif-
ference between the risk in men with microli-
thiasis (116 cases per 1,000 men) and the risk
in other men (15 cases per 1,000 men) (Table 1).
Thus, the attributable risk is 101 per 1,000
cases, meaning that in 1,000 men with microli-
thiasis, 101 testicular cancers could be pre-
vented (or detected earlier) if it were possible to
eliminate the risk factor of microlithiasis (or to
perform dedicated surveillance for those who
have it). In fact, among men with microlithiasis,
the attributable risk percentage is 87.0%, mean-
ing that 87.0% of testicular cancers in these
men are actually related to their microlithiasis.
How does this play out in the population as a
whole? The prevalence of microlithiasis in the
study population was 7.67%. Population-
attributable risk is the product of the attribut-
able risk in the exposed population and the
prevalence of that exposure in the total popula-
tion. Thus, the population-attributable risk is 8
per 1,000 cases, meaning that in the total popu-
lation, eight cases of testicular cancer per 1,000
men could be attributed to microlithiasis, consti-
tuting 33.6% of all testicular cancer in the pop-
ulation. The population-attributable risk
percentage of 33.6% means that 33.6% of testic-
ular cancer is associated with microlithiasis and
could potentially be prevented or its disease
course altered by modification of this risk factor.
Thus, a full one-third of testicular cancer was
attributable to microlithiasis in this study. The
authors note that their population is subject to
a selection bias because sonographic examina-
tions were only being performed in patients
with masses or other symptoms. This would
tend to overestimate the prevalence of both can-
cer and microlithiasis and may limit the gener-
alizability of these findings. Furthermore, as
noted above, the attributable-risk analysis pre-
sumes a causal–temporal sequence that cannot
be derived directly from cross-sectional data,
and this must be considered an additional limi-
tation. Generally, discussions of attributable
risk are based on incidence data (as can be
derived from a cohort study) rather than preva-
lence data, as in this cross-sectional study.
As such, calculations of attributable risk are
subject to bias associated with method of sam-
pling, and conclusions are valid only within the
population context of men undergoing scrotal
ultrasound.
Over the years, there has been little consen-
sus on the management of microlithiasis, and
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recommendations have covered the spectrum
from no follow-up through testicular self-exami-
nation,2 serial ultrasounds,3 and even testicular
biopsy.4 When viewed through the lens of attrib-
utable risk, the data in the study by Heller
et al lend support to the idea of testicular
microlithiasis as a true, although unfortunately
nonmodifiable, risk factor for testicular cancer.
Current science does not enable us to prevent
these cancers. However, this analysis under-
scores the need for standardized recommenda-
tions for clinical and imaging follow-up in
patients with microlithiasis, with the goal of
detecting cancer earlier and minimizing associ-
ated morbidity and mortality.
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TABLE 1
Attributable-Risk Calculations for Microlithiasis as a Risk Factor for Testicular Cancer in 6,002 Patients
Attributable Risk Attributable Risk Percentage
Definition Value Definition Value
Men with
microlithiasis
Disease rate among those
exposed to risk factor less
disease rate in unexposed
101 cases per
1,000 men
Attributable risk divided by disease
rate in exposed group 3 100
87.0%
Population as
a whole
Disease rate in total population
less disease rate in unexposed
8 cases per
1,000 men
Population-attributable risk divided
by disease rate in total population 3 100
33.6%
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